🇰🇷 South Korea Country × Condition
breast cancer Clinical Trials in South Korea
Active clinical trials for breast cancer with research sites in South Korea. All data sourced live from ClinicalTrials.gov — updated daily.
Active Trials: 3 // Recruiting: 3 Phases: Phase 1, Phase 2 // Updated: Daily
Total Trials
3
Recruiting Now
3
Country
🇰🇷 South Korea
Active Trials in South Korea (3)
NCT07803081
Recruiting
Radiotherapy and Long-term Outcomes in Early Breast Cancer With SLNB Omission
Enrollment
500 pts
Country
🇰🇷 South Korea
Samsung Medical Center
View Trial → NCT06265025 Phase 1, Phase 2
Recruiting
GM103 Intratumoral Injection in Patients With Locally Advanced, Unresectable, Refractory and/or Metastatic Solid Tumors
Enrollment
125 pts
Country
🇰🇷 South Korea
GeneMedicine Co., Ltd.
View Trial → NCT07327970
Recruiting
Prospective Validation of Ataraxis AI Test for Predicting Treatment Response in Neoadjuvant Breast Cancer
Enrollment
150 pts
Country
🇰🇷 South Korea
Young-Joon Kang
View Trial → Frequently Asked Questions
How many breast cancer clinical trials are active in South Korea?
There are currently 3 active clinical trials for breast cancer with sites in South Korea, of which 3 are actively recruiting patients.
How can I join a breast cancer clinical trial in South Korea?
To join a breast cancer clinical trial in South Korea, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in South Korea directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are breast cancer trials in South Korea?
Active breast cancer trials in South Korea span Phase 1, Phase 2. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology